<DOC>
	<DOCNO>NCT01271179</DOCNO>
	<brief_summary>The study design investigate whether , compare conventional sole perfusion high-viscosity solution University Wisconsin ( UW ) , sequential perfusion liver grafts low-viscosity high-viscosity preservation solution could decrease incidence nonanastomotic biliary stricture ( NAS ) liver transplantation .</brief_summary>
	<brief_title>Study Sequential Perfusion Liver Grafts Prevent Nonanastomotic Biliary Strictures After Liver Transplantation</brief_title>
	<detailed_description>The exact etiology nonanastomotic biliary stricture ( NAS ) patent hepatic artery liver transplantation remain unclear far . Microangiopathy strongly suspect involved etiology , sufficient flush peribiliary plexus ( PBP ) directly nourish donor biliary tree may pivotal prevent NAS patent hepatic artery . Solution University Wisconsin ( UW solution ) standard liver graft flushing , accuse high viscosity hyperaggregation effect erythrocytes ingredient hydroxyethyl starch well initial vasoconstriction high potassium content , together constitute hindrance solution penetration thorough flush liver microcirculation include PBP . Several study reveal relationship high viscosity UW solution development NAS . The investigator , therefore , hypothesize sequential perfusion low-viscosity high-viscosity preservation solution might improve patency PBP contrast conventional sole perfusion high-viscosity UW solution , result , incidence NAS patent hepatic artery liver transplantation would significantly decrease .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Cholestasis</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Adenosine</mesh_term>
	<mesh_term>Allopurinol</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>ageâ‰¥18 year ability provide write informed consent prior study entry receive whole liver graft primary transplantation participant clinical trial fulminant liver failure cause transplantation primary biliary cirrhosis , autoimmune hepatitis primary sclerosing cholangitis primary liver disease retransplantation nonliver organ ( ) failure prior study entry donor/recipient ABObloodgroupincompatibility</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>orthotopic liver transplantation</keyword>
	<keyword>preservation solution</keyword>
	<keyword>peribiliary plexus</keyword>
	<keyword>nonanastomotic biliary stricture</keyword>
	<keyword>primary non-function</keyword>
</DOC>